Invitae Corp (NVTAQ)
OTCMKTS: NVTAQ · Delayed Price · USD
0.0007
+0.0003 (75.00%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Invitae Market Cap
Invitae has a market cap or net worth of $171.90 thousand as of July 2, 2024. Its market cap has decreased by -99.97% in one year.
Market Cap
171.90K
Enterprise Value
1.24B
1-Year Change
-99.97%
Ranking
n/a
Category
Stock Price
$0.00
Market Cap Chart
Since February 12, 2015, Invitae's market cap has decreased from $508.10M to $171.90K, a decrease of -99.97%. That is a compound annual growth rate of -58.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2024 | 25.50M | -85.80% |
| Dec 29, 2023 | 179.60M | -60.25% |
| Dec 30, 2022 | 451.80M | -86.93% |
| Dec 31, 2021 | 3.46B | -53.21% |
| Dec 31, 2020 | 7.39B | 374.52% |
| Dec 31, 2019 | 1.56B | 88.65% |
| Dec 31, 2018 | 825.30M | 80.99% |
| Dec 29, 2017 | 456.00M | 77.02% |
| Dec 30, 2016 | 257.60M | -1.72% |
| Dec 31, 2015 | 262.10M | -48.42% |
| Feb 12, 2015 | 508.10M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 860.48B |
| Novo Nordisk | 629.27B |
| UnitedHealth Group | 468.72B |
| Johnson & Johnson | 351.76B |
| Merck & Co. | 313.56B |
| AbbVie | 302.88B |
| AstraZeneca | 241.81B |
| Thermo Fisher | 211.09B |